Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tachyon Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Tachyon Therapeutics

Tachyon Therapeutics

Series A

Tachyon Therapeutics: Innovating cancer treatment through selective compounds and advanced clinical research.

HQ
San Francisco, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Tachyon Therapeutics, founded with a mission to innovate cancer treatment, focuses on developing novel, selective compounds to improve patient outcomes. The company's vision is to accelerate the development of first-in-class therapeutics targeting significant new drug targets in oncology. Tachyon's flagship product, TACH101, is currently in Phase 1 clinical trials to evaluate its safety, pharmacokinetics, and anti-tumor activity in patients with advanced cancer.

Notable figures affiliated with Tachyon Therapeutics include a distinguished management team and a board of directors with extensive experience in biotechnology and pharmaceuticals. The company has garnered attention from prominent investors in the healthcare sector. Key achievements include the initiation of multicenter Phase 1 clinical studies for TACH101, demonstrating their commitment to advancing cancer treatment. Tachyon Therapeutics' innovative approach has the potential to significantly impact the oncology field by providing new, effective treatment options for cancer patients.

Tachyon Therapeutics - Similar Companies

Tactiva Therapeutics logo

Tactiva Therapeutics

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Palm Therapeutics logo

Palm Therapeutics

Treadwell Therapeutics logo

Treadwell Therapeutics

treadwelltx.com

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

OncoSpherix logo

OncoSpherix

oncospherix.com

Onchilles Pharma logo

Onchilles Pharma

Parthenon Therapeutics logo

Parthenon Therapeutics

parthenontx.com

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

Telo Therapeutics logo

Telo Therapeutics

Camino Pharma logo

Camino Pharma

caminopharma.com

Tychon Bioscience logo

Tychon Bioscience

tychonbio.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Tau Therapeutics logo

Tau Therapeutics

Ostentus Therapeutics logo

Ostentus Therapeutics

Tachyon Therapeutics - Quick Facts

Who are Tachyon Therapeutics' competitors?

Companies similar to Tachyon Therapeutics include Tactiva Therapeutics, PanTher Therapeutics, Palm Therapeutics and Treadwell Therapeutics.

When was Tachyon Therapeutics founded?

Tachyon Therapeutics was founded in 2019.

Where is Tachyon Therapeutics' headquarters located?

Tachyon Therapeutics' headquarters is located in San Francisco, CA, US.

When was Tachyon Therapeutics' last funding round?

Tachyon Therapeutics' most recent funding round was for $7.1M (USD) in March 2023.

How much has Tachyon Therapeutics raised to-date?

As of Mar 1, 2023, Tachyon Therapeutics has raised a total of $18.7M (USD).

How many employees does Tachyon Therapeutics have?

Tachyon Therapeutics has 5 employees as of Feb 4, 2024.

Tachyon Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified